PD-L1 (SP142) Ventana for TNBC
PD-L1 (SP142) Ventana لسرطان الثدي الثلاثي السلبي (TNBC)
Sample Type
🧪 Tissue
Results In
⏱ 15 Days
Fasting
✅ Not Required
Parameters
📊 1
What is PD-L1 (SP142) Ventana for TNBC?
This test specifically measures PD-L1 protein levels on tumor-infiltrating immune cells using the SP142 antibody, particularly relevant for Triple-Negative Breast Cancer (TNBC). It helps determine if patients with TNBC might benefit from certain immunotherapy drugs.
Why is this test important?
The PD-L1 (SP142) test is crucial for treatment stratification in Triple-Negative Breast Cancer (TNBC), a particularly aggressive form of breast cancer. Positive results indicate potential responsiveness to specific immunotherapies, offering new treatment avenues.
How to Prepare
No special preparation required. This test is performed on a tissue sample typically obtained through a biopsy.
Frequently Asked Questions
Do I need to fast before my blood test?▼
Related Tests
Medical Disclaimer: The information on this page is for educational purposes only and should not be considered medical advice. Always consult your physician or qualified healthcare provider for diagnosis and treatment. Test results should be interpreted by a qualified medical professional.